Zobrazeno 1 - 10
of 73
pro vyhledávání: '"miocardiopatías"'
Publikováno v:
Archivos de Cardiología de México, Vol 92, Iss 3 (2022)
La Miocardiopatía Hipertrófica es una entidad clínica que ha sido sometida durante años a cambios frecuentes en su denominación, en gran parte consecuencia de su heterogeneidad morfológica y funcional, lo que hace que el clínico enfocado a su
Externí odkaz:
https://doaj.org/article/d395e22dbaf4420a9a14dad8959375f2
Autor:
Eusebio García-Izquierdo Jaén, Juan Francisco Oteo Domínguez, Marta Jiménez Blanco, Cristina Aguilera Agudo, Fernando Domínguez, Jorge Toquero Ramos, Javier Segovia Cubero, Clara Salas Antón, Arturo García-Touchard, José Antonio Fernández-Díaz, Rodrigo Estévez-Loureiro, Francisco Javier Goicolea Ruigómez, Luis Alonso-Pulpón
Publikováno v:
REC: Interventional Cardiology, Vol 1, Iss 2, Pp 99-107 (2019)
RESUMEN Introducción y objetivos: La biopsia endomiocárdica (BEM) es una técnica diagnóstica fundamental en el diagnóstico de distintas miocardiopatías, pero no está exenta de posibles complicaciones. Se presentan los resultados en términos d
Externí odkaz:
https://doaj.org/article/ae2a1cd99be8403d8e214c14bb0cee16
Publikováno v:
Revista Colombiana de Cardiología, Vol 28, Iss 6 (2021)
La muerte súbita cardiaca es una consecuencia devastadora de las enfermedades estructurales del corazón y un problema de salud pública en todo el mundo; es responsable de alrededor del 50% de las muertes por causa cardiovascular. Su incidencia es
Externí odkaz:
https://doaj.org/article/1f30eb4ee3de441f8041681e794f35c6
Publikováno v:
Universidad Médica Pinareña, Vol 16, Iss 3, Pp e521-e521 (2020)
Introduction: COVID-19 is an emerging disease with global incidence, which exhibits a greater number of complications in patients with comorbidities, mainly in those with a history of cardiovascular disease. Objective: to describe the implications o
Externí odkaz:
https://doaj.org/article/baac92eb1565426789ee1c501f410e3d
Autor:
Dr Diego Pérez de Arenaza
Publikováno v:
Revista Médica Clínica Las Condes, Vol 29, Iss 1, Pp 44-53 (2018)
La resonancia magnética cardiovascular (RMC) es una técnica de imágenes establecida en la evaluación de pacientes con miocardiopatías. El aspecto más relevante de la RMC es la caracterización tisular para la identificación de la fibrosis medi
Externí odkaz:
https://doaj.org/article/012d4528d252472b854b1ef85080a308
Publikováno v:
1. De Angelis G, Bobbo M, Paldino A, D’Agata Mottolese B, Altinier A, Dal Ferro M, et al. Cardiomyopathies in children. Curr Opin Organ Transplant [Internet]. 2020Jun;25(3):218–30. Available from: http://journals.lww.com/10.1097/MOT.0000000000000755
2. Lipshultz SE, Cochran TR, Briston DA, Brown SR, Sambatakos PJ, Miller TL, et al. Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive estrategies and therapies. Future Cardiol [Internet]. 2013 Nov;9(6):817–48. Available from: https://www.futuremedicine.com/doi/abs/10.2217/fca.13.66
3. Konta L, Franklin RCG, Kaski JP. Nomenclature and systems of classification for cardiomyopathy in children. Cardiol Young [Internet]. 2015 Aug 17;25(S2):31–42.Availablefrom:https://www.cambridge.org/core/product/identifier/S1047951115001201/type/journal_article
4. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Heart [Internet]. 1980 Dec 1;44(6):672–3. Available from:http://heart.bmj.com/cgi/doi/10.1136/hrt.44.6.672
5. Mathew J, Zahavich L, Lafreniere-Roula M, Wilson J, George K, Benson L, et al. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy. Clin Genet[Internet]. 2018 Feb;93(2):310–9.Available from: http://doi.wiley.com/10.1111/cge.13157
6. Ware SM. Cardiomyopathy in Children. J Am Coll Cardiol [Internet]. 2018Nov;72(19):2339–41. Available from:https://linkinghub.elsevier.com/retrieve/pii/S073510971838402X
7. Huertas-Quiñones VM, Restrepo CM. Genética de las Cardiopatías Congénitas. Capítulo 15. Bloque 4-Genética del Corazón y sus estructuras. En López-Farré. Cardio-Genética. Primera ed. Sociedad Española de Cardiología, Universidad Complutense de Madrid. Editorial médica CTO. Madrid (España) 2015:175-202.ISBN 978-84-16153-91-6.
8. Miocardiopatia dilatada [Internet]. 2018. Available from: https://healthincode.com/en/panels/cardiology/cardiomyopathy/dilated-cardiomyopathy/
9. Huertas-Quiñones VM. Cardiomiopatías en edad pediátrica. En “Cardiología Pediátrica”. Díaz GF, Sandoval N, Vélez JF, ed. Segunda ed. Sociedad Colombiana de Cardiología. Editorial Distribuna. Bogotá (Colombia)2018:941-974. ISBN 978-958-8813-70-7.
11. Monserrat L, Ochoa J, Garcia D, Ortiz M. Genética de la miocardiopatia hipertrofica. In: CTO E médica, editor. Cardio-genética. Primera ed. Madrid, España; 2015. p. 41–53.
12. Levine GN. Restrictive Cardiomyopathy. In: Cardiology Secrets [Internet]. Elsevier;2010. p. 203–6. Available from: https://www.elsevier.com/books/cardiology-secrets/levine/978-0-323-47870-0
13. Barredo M, Gonzalez J. Genética de la miocardiopatía restrictiva cardiaca. In: Cardiogenética. Primera edición. Madrid, España: Editorial médica CTO; 2015. p. 57–66.
14. Sabaté Rotés A, Huertas-Quiñones VM, Betrián P, Carretero J, Jiménez L, Girona J, et al. Miocardiopatía no compactada: características clínicas, evolutivas y pronósticas en edad pediátrica. Resultados de un estudio multicéntrico. An Pediatr. 2012 Dec;77(6):360–5
15. Miocardiopatia no compacta [Internet]. 2018. Available from:https://cardio.healthincode.com/genetica-cardiovascular/miocardiopatias/no-compactada
16. Monserrat Iglesias L. Miocardiopatía no compactada: una enfermedad en busca de criterios. Rev Española Cardiol [Internet]. 2008 Feb;61(2):112–5. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0300893208733566
17. Lee TM, Hsu DT, Kantor P, Towbin JA, Ware SM, Colan SD, et al. Pediatric Cardiomyopathies. Circ Res [Internet]. 2017 Sep 15;121(7):855–73. Available from: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.116.309386
18. Yuan S-M. Cardiomyopathy in the pediatric patients. Pediatr Neonatol [Internet]. 2018Apr;59(2):120–8. Available from: https://www.sciencedirect.com/science/article/pii/S1875957218300342
19. Huertas-Quiñones VM, Mestra CF, Peña-Trujillo V, Gallo-Bernal S, Villaveces M, Alarcón-Forero LC. Paediatric cardiomyopathies: echocardiographic diagnosis, clinical profile, and demographic characteristics: the experience of a tertiary referral centre for Latin American paediatric cardiology. Cardiol Young [Internet]. 2020 Apr 17;30(4):462– Available from:https://www.cambridge.org/core/product/identifier/S1047951120000281/type/journal_article
20. Lipshultz SE, Law YM, Asante-Korang A, Austin ED, Dipchand AI, Everitt MD, et al. Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association. Circulation [Internet]. 2019 Jul 2;140(1). Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000682
21. Yotti R, Seidman CE, Seidman JG. Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies. Annu Rev Genomics Hum Genet [Internet]. 2019 Aug 31;20(1):129–53. Available from: https://www.annualreviews.org/doi/10.1146/annurev-genom-083118-015306
22. Jordan E, Peterson L, Ai T, Asatryan B, Bronicki L, Brown E, et al. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy. Circulation [Internet]. 2021 Jul 6;144(1):7–19. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.053033
23. Lakdawala NK, Dellefave L, Redwood CS, Sparks E, Cirino AL, Depalma S, et al. Familial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin Mutation. J Am Coll Cardiol [Internet]. 2010 Jan;55(4):320–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0735109709037784
24. Xiao L, Li C, Sun Y, Chen Y, Wei H, Hu D, et al. Clinical Significance of Variants in the TTN Gene in a Large Cohort of Patients With Sporadic Dilated Cardiomyopathy. Front Cardiovasc Med [Internet]. 2021 Apr 30;8. Available from: https://www.frontiersin.org/articles/10.3389/fcvm.2021.657689/full
25. Liew C-C, Sole MJ, Yamauchi-Takihara K, Kellam B, Anderson DH, Lin L, et al. Complete sequence and organization of the human cardiac β-myosin heavy chain gene. Nucleic Acids Res [Internet]. 1990;18(12):3647–51. Available from: https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/18.12.3647
26. Bang M-L, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, et al. The Complete Gene Sequence of Titin, Expression of an Unusual ≈700-kDa Titin Isoform, and Its Interaction With Obscurin Identify a Novel Z-Line to I-Band Linking System. Circ Res [Internet]. 2001 Nov 23;89(11):1065–72. Available from: https://www.ahajournals.org/doi/10.1161/hh2301.100981
27. Fananapazir L, Dalakas MC, Cyran F, Cohn G, Epstein ND. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci [Internet]. 1993 May;90(9):3993–7. Available from: https://pnas.org/doi/full/10.1073/pnas.90.9.3993
28. Myosin, heavy chain 7, cardiac muscle, beta; MYH7 [Internet]. 2018. Available from: https://www.omim.org/entry/160760
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
2. Lipshultz SE, Cochran TR, Briston DA, Brown SR, Sambatakos PJ, Miller TL, et al. Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive estrategies and therapies. Future Cardiol [Internet]. 2013 Nov;9(6):817–48. Available from: https://www.futuremedicine.com/doi/abs/10.2217/fca.13.66
3. Konta L, Franklin RCG, Kaski JP. Nomenclature and systems of classification for cardiomyopathy in children. Cardiol Young [Internet]. 2015 Aug 17;25(S2):31–42.Availablefrom:https://www.cambridge.org/core/product/identifier/S1047951115001201/type/journal_article
4. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Heart [Internet]. 1980 Dec 1;44(6):672–3. Available from:http://heart.bmj.com/cgi/doi/10.1136/hrt.44.6.672
5. Mathew J, Zahavich L, Lafreniere-Roula M, Wilson J, George K, Benson L, et al. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy. Clin Genet[Internet]. 2018 Feb;93(2):310–9.Available from: http://doi.wiley.com/10.1111/cge.13157
6. Ware SM. Cardiomyopathy in Children. J Am Coll Cardiol [Internet]. 2018Nov;72(19):2339–41. Available from:https://linkinghub.elsevier.com/retrieve/pii/S073510971838402X
7. Huertas-Quiñones VM, Restrepo CM. Genética de las Cardiopatías Congénitas. Capítulo 15. Bloque 4-Genética del Corazón y sus estructuras. En López-Farré. Cardio-Genética. Primera ed. Sociedad Española de Cardiología, Universidad Complutense de Madrid. Editorial médica CTO. Madrid (España) 2015:175-202.ISBN 978-84-16153-91-6.
8. Miocardiopatia dilatada [Internet]. 2018. Available from: https://healthincode.com/en/panels/cardiology/cardiomyopathy/dilated-cardiomyopathy/
9. Huertas-Quiñones VM. Cardiomiopatías en edad pediátrica. En “Cardiología Pediátrica”. Díaz GF, Sandoval N, Vélez JF, ed. Segunda ed. Sociedad Colombiana de Cardiología. Editorial Distribuna. Bogotá (Colombia)2018:941-974. ISBN 978-958-8813-70-7.
11. Monserrat L, Ochoa J, Garcia D, Ortiz M. Genética de la miocardiopatia hipertrofica. In: CTO E médica, editor. Cardio-genética. Primera ed. Madrid, España; 2015. p. 41–53.
12. Levine GN. Restrictive Cardiomyopathy. In: Cardiology Secrets [Internet]. Elsevier;2010. p. 203–6. Available from: https://www.elsevier.com/books/cardiology-secrets/levine/978-0-323-47870-0
13. Barredo M, Gonzalez J. Genética de la miocardiopatía restrictiva cardiaca. In: Cardiogenética. Primera edición. Madrid, España: Editorial médica CTO; 2015. p. 57–66.
14. Sabaté Rotés A, Huertas-Quiñones VM, Betrián P, Carretero J, Jiménez L, Girona J, et al. Miocardiopatía no compactada: características clínicas, evolutivas y pronósticas en edad pediátrica. Resultados de un estudio multicéntrico. An Pediatr. 2012 Dec;77(6):360–5
15. Miocardiopatia no compacta [Internet]. 2018. Available from:https://cardio.healthincode.com/genetica-cardiovascular/miocardiopatias/no-compactada
16. Monserrat Iglesias L. Miocardiopatía no compactada: una enfermedad en busca de criterios. Rev Española Cardiol [Internet]. 2008 Feb;61(2):112–5. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0300893208733566
17. Lee TM, Hsu DT, Kantor P, Towbin JA, Ware SM, Colan SD, et al. Pediatric Cardiomyopathies. Circ Res [Internet]. 2017 Sep 15;121(7):855–73. Available from: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.116.309386
18. Yuan S-M. Cardiomyopathy in the pediatric patients. Pediatr Neonatol [Internet]. 2018Apr;59(2):120–8. Available from: https://www.sciencedirect.com/science/article/pii/S1875957218300342
19. Huertas-Quiñones VM, Mestra CF, Peña-Trujillo V, Gallo-Bernal S, Villaveces M, Alarcón-Forero LC. Paediatric cardiomyopathies: echocardiographic diagnosis, clinical profile, and demographic characteristics: the experience of a tertiary referral centre for Latin American paediatric cardiology. Cardiol Young [Internet]. 2020 Apr 17;30(4):462– Available from:https://www.cambridge.org/core/product/identifier/S1047951120000281/type/journal_article
20. Lipshultz SE, Law YM, Asante-Korang A, Austin ED, Dipchand AI, Everitt MD, et al. Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association. Circulation [Internet]. 2019 Jul 2;140(1). Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000682
21. Yotti R, Seidman CE, Seidman JG. Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies. Annu Rev Genomics Hum Genet [Internet]. 2019 Aug 31;20(1):129–53. Available from: https://www.annualreviews.org/doi/10.1146/annurev-genom-083118-015306
22. Jordan E, Peterson L, Ai T, Asatryan B, Bronicki L, Brown E, et al. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy. Circulation [Internet]. 2021 Jul 6;144(1):7–19. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.053033
23. Lakdawala NK, Dellefave L, Redwood CS, Sparks E, Cirino AL, Depalma S, et al. Familial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin Mutation. J Am Coll Cardiol [Internet]. 2010 Jan;55(4):320–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0735109709037784
24. Xiao L, Li C, Sun Y, Chen Y, Wei H, Hu D, et al. Clinical Significance of Variants in the TTN Gene in a Large Cohort of Patients With Sporadic Dilated Cardiomyopathy. Front Cardiovasc Med [Internet]. 2021 Apr 30;8. Available from: https://www.frontiersin.org/articles/10.3389/fcvm.2021.657689/full
25. Liew C-C, Sole MJ, Yamauchi-Takihara K, Kellam B, Anderson DH, Lin L, et al. Complete sequence and organization of the human cardiac β-myosin heavy chain gene. Nucleic Acids Res [Internet]. 1990;18(12):3647–51. Available from: https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/18.12.3647
26. Bang M-L, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, et al. The Complete Gene Sequence of Titin, Expression of an Unusual ≈700-kDa Titin Isoform, and Its Interaction With Obscurin Identify a Novel Z-Line to I-Band Linking System. Circ Res [Internet]. 2001 Nov 23;89(11):1065–72. Available from: https://www.ahajournals.org/doi/10.1161/hh2301.100981
27. Fananapazir L, Dalakas MC, Cyran F, Cohn G, Epstein ND. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci [Internet]. 1993 May;90(9):3993–7. Available from: https://pnas.org/doi/full/10.1073/pnas.90.9.3993
28. Myosin, heavy chain 7, cardiac muscle, beta; MYH7 [Internet]. 2018. Available from: https://www.omim.org/entry/160760
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: Las miocardiopatías son un grupo heterogéneo de entidades que comprometen la función y estructura del músculo cardíaco, generando disfunción miocárdica, falla cardíaca e inclusive muerte súbita. La literatura Latinoamérica es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e86139abd08216d585f6ef3ed2c13a
https://repository.urosario.edu.co/handle/10336/34538
https://repository.urosario.edu.co/handle/10336/34538
Publikováno v:
Acta Pediátrica de México, Vol 35, Iss 2, Pp 97-103 (2014)
Restrictive cardiomyopathy is a disease characterized by ventricular diastolic failure with elevation of end-dyastolic pressure and preserved systolic function. Materials and methods: retrospective study of patients with a diagnosis of restrictive ca
Externí odkaz:
https://doaj.org/article/9591bb470bf74af19370f886bca3d98d
Publikováno v:
Revista Colombiana de Cardiología, Volume: 28, Issue: 6, Pages: 604-615, Published: 07 JAN 2022
Resumen La muerte súbita cardiaca es una consecuencia devastadora de las enfermedades estructurales del corazón y un problema de salud pública en todo el mundo; es responsable de alrededor del 50% de las muertes por causa cardiovascular. Su incide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______618::6ba26cff7b0e14b8ef67839eb8d50635
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-56332021000600604&lng=en&tlng=en
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-56332021000600604&lng=en&tlng=en
Autor:
Escribá Piera, Rubén
Publikováno v:
TDX (Tesis Doctorals en Xarxa)
TDR. Tesis Doctorales en Red
Fundación Tecnalia Research & Innovation
Dipòsit Digital de la UB
Universidad de Barcelona
TDR. Tesis Doctorales en Red
Fundación Tecnalia Research & Innovation
Dipòsit Digital de la UB
Universidad de Barcelona
[eng] Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease and a frequent cause of heart failure and sudden cardiac death. HCM is a highly complex condition defined by clinical and genetic heterogeneity. During last decades,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9afa7427129739b0be139d0ae5ccde21
http://hdl.handle.net/10803/674443
http://hdl.handle.net/10803/674443
Publikováno v:
Revista Peruana de Medicina Experimental y Salud Pública, Vol 28, Iss 2, Pp 264-272 (2011)
Objetivos. Evaluar el efecto de atorvastatina sobre la progresión del remodelado cardiaco y la expresión de ECA-2 en el miocardio de ratas diabéticas. Materiales y métodos. La diabetes fue inducida en ratas Holtzman con una inyección intraperito
Externí odkaz:
https://doaj.org/article/86f9325457bc4a63814816fcfd2b7406